Difference between revisions of "Team:Tongji Shanghai"

 
(One intermediate revision by the same user not shown)
Line 103: Line 103:
 
                 <div class="qoute-box">
 
                 <div class="qoute-box">
 
                   <a>  
 
                   <a>  
−
                      <h2>We want to create a Golden Era for breast cancer patients with system OPTT (optimized photothermal therapy), a breast tumor killer.</h2>
+
 
 +
<h2>We want to create a Golden Era for breast cancer patients with system OPTT (optimized photothermal therapy), a breast tumor killer.</h2>
  
 
<h2>Breast cancer is the culprit which breaks up hundreds of thousands of women’s delicate beauty and health. Photothermal therapy (PTT) has exhibited the significant potential for solid tumors treatment. However, it still has some drawbacks including off-target effect and the lack of visualization towards agent delivery.</h2>
 
<h2>Breast cancer is the culprit which breaks up hundreds of thousands of women’s delicate beauty and health. Photothermal therapy (PTT) has exhibited the significant potential for solid tumors treatment. However, it still has some drawbacks including off-target effect and the lack of visualization towards agent delivery.</h2>
Line 109: Line 110:
 
<h2>To minimize the shortcomings, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system which can achieve visualization and reduce the off-target effect of original photothermal therapy. </h2>
 
<h2>To minimize the shortcomings, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system which can achieve visualization and reduce the off-target effect of original photothermal therapy. </h2>
  
−
<h2>By combining gold nanorods with constructed plasmids, our system will open a Golden Era for breast cancer patients. Era is the acronym of “Efficiency, Reportability and Accuracy”, which generalizes the characteristics of our products. We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells but not normal cells. With the aid of luciferase, we can observe if the tumor cells had been heat treated, which can solve the visualization problem. Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.
+
<h2>By combining gold nanorods with constructed plasmids, our system will open a Golden Era for breast cancer patients. Era is the acronym of “Efficiency, Reporter and Accuracy”, which generalizes the characteristics of our products. We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells but not normal cells. With the aid of luciferase, we can observe if the tumor cells had been heat treated, which can solve the visualization problem. Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.
 
</h2>
 
</h2>
  
Line 137: Line 138:
 
             </div>
 
             </div>
 
             <div class="service-content">
 
             <div class="service-content">
−
               <h2>Reportable</h2>
+
               <h2>Reporter</h2>
 
             <ul style="font-size:15px; margin-left:0px;">With the aid of luciferase, we can observe if the tumor cells had been heat treated in in vivo bioluminescence imaging machine with the injection of luciferase substance.</ul>
 
             <ul style="font-size:15px; margin-left:0px;">With the aid of luciferase, we can observe if the tumor cells had been heat treated in in vivo bioluminescence imaging machine with the injection of luciferase substance.</ul>
 
             </div>
 
             </div>
Line 182: Line 183:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/95/T--Tongji_Shanghai--Member_individual_ZHUYUMENG.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/95/T--Tongji_Shanghai--Member_individual_ZHUYUMENG.jpg" />
−
                         <div class="member-name">ZHU Yumeng<span>Researcher</span></div>
+
                         <div class="member-name">ZHU Yumeng<span>Manager</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 192: Line 193:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/8/85/T--Tongji_Shanghai--Member_individual_TANGYINGLU.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/8/85/T--Tongji_Shanghai--Member_individual_TANGYINGLU.jpg" />
−
                         <div class="member-name">TANG Yinglu<span>Researcher</span></div>
+
                         <div class="member-name">TANG Yinglu<span>Implementer</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 213: Line 214:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/6/61/T--Tongji_Shanghai--Member_individual_ZHOUDANLEI.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/6/61/T--Tongji_Shanghai--Member_individual_ZHOUDANLEI.jpg" />
−
                         <div class="member-name">ZHOU Danlei<span>ME</span></div>
+
                         <div class="member-name">ZHOU Danlei<span>Evaluator</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 274: Line 275:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/99/T--Tongji_Shanghai--Member_individual_RENQIAN.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/99/T--Tongji_Shanghai--Member_individual_RENQIAN.jpg" />
−
                         <div class="member-name">REN Qian<span>Researcher</span></div>
+
                         <div class="member-name">REN Qian<span>Implementer</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>

Latest revision as of 05:48, 19 October 2016

Tongji_Shanghai-2016.igem.org Tongji Shanghai

Abstract

We want to create a Golden Era for breast cancer patients with system OPTT (optimized photothermal therapy), a breast tumor killer.

Breast cancer is the culprit which breaks up hundreds of thousands of women’s delicate beauty and health. Photothermal therapy (PTT) has exhibited the significant potential for solid tumors treatment. However, it still has some drawbacks including off-target effect and the lack of visualization towards agent delivery.

To minimize the shortcomings, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system which can achieve visualization and reduce the off-target effect of original photothermal therapy.

By combining gold nanorods with constructed plasmids, our system will open a Golden Era for breast cancer patients. Era is the acronym of “Efficiency, Reporter and Accuracy”, which generalizes the characteristics of our products. We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells but not normal cells. With the aid of luciferase, we can observe if the tumor cells had been heat treated, which can solve the visualization problem. Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.

2016 iGEM Tongji Shanghai

Efficiency

    We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells.

Reporter

    With the aid of luciferase, we can observe if the tumor cells had been heat treated in in vivo bioluminescence imaging machine with the injection of luciferase substance.

Accuracy

    Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.

Meet Our Team

ZHANG JiaweiCaptain
WANG WillDesigner
ZHU YumengManager
TANG YingluImplementer
ZHOU XingyuResearcher
ZHOU DanleiEvaluator
LYU TongResearcher
HU ZhangsenResearcher
WU HongguiIdea Seeker
ZHU YajieCoordinator
REN QianImplementer
XU ChenruiSpecialist